Abstract
Cancer is one of the oldest diseases afflicting mankind, and the efforts at treatment have been recorded as long ago as the use of arsenic pastes in ancient Egypt. Today, cancer is second only to cardiovascular disease as the major cause of death in the United States. Each year, an estimated 650,000 new cases are diagnosed, and over 1 million known patients continue treatment. The major difficulties in mounting a rapid scientific assault on cancer are that it encompasses more than 100 clinically distinct diseases and is inextricably linked to fundamental life processes which still are not completely understood.
Chapter PDF
References
Burroughs Wellcome Company (1973). Information for investigators: Corynebacterium parvum (Wellcome, CN. 6134 ), Research Triangle Park, North Carolina.
Fisher, J. C., Grace, W. R., and Mannick, J. A. (1970). The effect of nonspecific immunostimulation with Corynebacterium parvum on patterns of tumor growth. Cancer 26: 1379–1382.
Freireich, E. J., Gehan, E. A., Rall, D. P., Schmidt, L. H., and Skipper, H. E. (1966). Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Cancer Chemother. Rep. 50: 219–244.
Halpern, B. N. and Israel, L. (1971). Etude de l’action d’une immunostimuline associée aux Corynébactéries anaérobies dans les neoplasies expérimentales et humaines. C. R. Acad. Sci. 273: 2186–2190.
Halpern, B. N., Biozzi, G., Stiffel, C., and Mouton, D. (1966). Inhibition of tumor growth by administration of killed Corynebacterium parvum. Nature (Lond.) 212: 853–854.
Israel, L. (1974). Clinical results with corynebacteria. Symposium on Cancer and Immunity (G. Mathé, ed.) ( Centre National de la Recherche Scientifique ), Paris.
Israel, L. and Edelstein, R. (1974). Nonspecific immunostimulation with C. parvum in human cancer. Symposium on Immune Mechanisms in Neoplasia. M. D. Anderson Hospital and Tumor Institute, Houston.
Israel, L. and Halpern, B. N. (1972). Le Corynebacterium parvum dans les cancer avancés. Première evaluation de l’activité thérapeutique de cette immunostiumline. Nouv. Presse Med. 1: 19–23.
Kenis, Y. (1969). Dose schedules and modes of administration of chemotherapeutic agents in man. Recent Results Cancer Res. 21: 54–61.
Lamensans, A., Stiffel, C., Mollier, M. F., Laurent, M., Mouton, D., and Biozzi, G. (1968). Effet protecteur de Corynebacterium parvum contre la leucemie greffée AKR. Rev. Fr. Etud. Clin. Biol. 13: 772–776.
Milas, L. and Mujagić, H. (1972). Protection by Corynebacterium parvum against tumor cells injected intravenously. Eur. J. Clin. Biol. Res. 17: 498–500.
Pinkel, D. (1958). The use of body-surface area as a criterion of drug dosage in cancer chemotherapy. Cancer Res. 18: 853–856.
Prévot, A. R., Halpern, B. N., Biozzi, G., Stiffel, C., Mouton, D., Morard, J. C., Bouthillier, Y., and Decreusefond, (1973). Stimulation du système réticuloendothélial par les corps microbiens tués de Corynebacterium parvum. C. R. Acad. Sci. (Paris) 257: 13–17.
Schein, P. S., Davis, R. D., Carter, S., Newman, J., Schein, D. R., and Rall, D. A. (1970). The evaluation of anticancer drugs in dogs and monkeys for the prediction of qualitative toxicities in man. Clin. Pharmacol. Ther. 11: 3–40.
Shirkey, H. C. (1965). Drug dosage for infants and children. J. Am. Med. Assoc. 193: 443–446.
Smith, L. H. and Woodruff, M. E. A. (1968). Comparative effects of two strains of Corynebacterium parvum on phagocytic activity and tumor growth. Nature (Lond.) 219: 197–198.
Woodruff, M. E. A. and Inchley, M. P. (1971). Synergistic inhibition of mammary carcinoma transplants in A-strain mice by antitumor globulin and C. parvum. Br. J. Cancer 25: 584–593.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Plenum Press, New York
About this chapter
Cite this chapter
Carter, S.K., Slavik, M. (1975). A Chemotherapeutic Perspective on Clinical Trials with Corynebacterium parvum . In: Halpern, B. (eds) Corynebacterium Parvum. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-4428-5_37
Download citation
DOI: https://doi.org/10.1007/978-1-4613-4428-5_37
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4430-8
Online ISBN: 978-1-4613-4428-5
eBook Packages: Springer Book Archive